Hemostats Market Size And Forecast
According to Verified Market Research, The Global Hemostats market was valued at USD 2.15 Billion in 2018 and is projected to reach USD 3.38 Billion by 2026, growing at a CAGR of 5.76% from 2019 to 2026.
The latest survey on Global Hemostats Market is conducted covering various organizations of the industry from different geographies to come up with a 100+ page report. The study is a perfect mix of qualitative and quantitative information highlighting key market developments, challenges that industry and competition are facing along with gap analysis and new opportunity available and trend in Hemostats Market. The report bridges the historical data from 2013 to 2018 and forecasted till 2026. The report aims to present the analysis of Global Hemostats Market By Configuration, By Node Size, By Technology, By Vertical, By Region - North America, Europe, South America, Asia-Pacific, Middle East, and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities.
What Is Hemostat?
Hemostat is a surgical tool which is used to control bleeding while surgery. Due to this reason it is used at the initial stage of the surgery for initial incision to be lined with hemostats which close blood vessels awaiting ligation. Hemostats are used as tissue sealants and adhesion agent. These tissue sealant and adhesion agents have two brief classes viz. physical agents and biological substrates.
Global Hemostats Market Outlook
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
Conventional sutures for wound and incision closure are being replaced by tissue sealants, tissue adhesives and adhesion prevention products. Minimal invasive application, improved visualization, reduced operating time, prevention of leakage of non-blood fluids and reduced post-operative infection risks are the advantages of tissue sealants, tissue adhesives and adhesion prevention products which reduces hospital stays; indirectly the total medical cost. The medical tourism industry, increase in purchasing power, rapidly improving healthcare infrastructure and increased awareness about the healthcare practices might drive the hemostats market. However, the high cost of hemostats, government's rules and regulations, and requirement of skilled professional restraint the growth of the hemostats market growth.
Verified Market Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements which interests the client. The "Global Hemostats Market" is mainly bifurcated into sub-segments which can provide a classified data regarding latest trends in the market.
Global Hemostats Market Competitive Landscape
The "Global Hemostats Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as B. Braun Melsungen AG, Baxter International, Inc., CR Bard, Inc., Ethicon, Inc., Gelita Medical GmbH, Integra LifeSciences, Marine Polymer Technologies, Inc., Pfizer, Inc., Teleflex, and Z-Medica LLC. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.
Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
1 INTRODUCTION OF GLOBAL HEMOSTATS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL HEMOSTATS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
5 GLOBAL HEMOSTATS MARKET, BY PRODUCT
5.1 Overview
5.2 Thrombin-Based Hemostats
5.3 Oxidized Regenerated Cellulose-Based Hemostats
5.4 Collagen-Based Hemostats
5.5 Others
6 GLOBAL HEMOSTATS MARKET, BY FORMULATION
6.1 Overview
6.2 Matrix & Gel Hemostats
6.3 Sheet & Pad Hemostats
6.4 Sponge Hemostats
6.5 Powder Hemostats
7 GLOBAL HEMOSTATS MARKET, BY APPLICATION
7.1 Overview
7.2 Orthopedic Surgery
7.3 General Surgery
7.4 Neurological Surgery
7.5 Cardiovascular Surgery
7.6 Gynecological Surgery
7.7 Other Surgeries
8 GLOBAL HEMOSTATS MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Rest of the World
8.5.1 Latin America
8.5.2 Middle East
9 GLOBAL HEMOSTATS MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies
10 COMPANY PROFILES
10.1 B. Braun Melsungen AG
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Baxter International, Inc.
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 CR Bard, Inc.
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Ethicon, Inc.
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Gelita Medical GmbH
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Integra LifeSciences
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Marine Polymer Technologies, Inc.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Pfizer, Inc.
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Teleflex
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Z-Medica LLC
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
11 Appendix
11.1 Related Research
| Price : US$ 3500 | Date : Jun 2023 |
| Category : Healthcare and Pharmaceuticals | Pages : 161 |
| Price : US$ 3500 | Date : Jun 2023 |
| Category : Healthcare and Pharmaceuticals | Pages : 161 |
| Price : US$ 3500 | Date : Apr 2023 |
| Category : Services | Pages : 169 |
| Price : US$ 3500 | Date : Apr 2023 |
| Category : Services | Pages : 160 |
| Price : US$ 3500 | Date : Apr 2023 |
| Category : Services | Pages : 152 |
We will be happy to help you find what you need. Please call us or write to us:
Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).
This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection
Request Sample 
Request Discount 
Inquire Before Buy
